# Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

> **NCT00926016** · NA · COMPLETED · sponsor: **Brooke Army Medical Center** · enrollment: 23 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pioglitazone (Actos)

## Key facts

- **NCT ID:** NCT00926016
- **Lead sponsor:** Brooke Army Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2012-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926016, "Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00926016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*